MoneyWorks4Me

Solara Active Pharma Sciences gets nod to sell 100% stake in SeQuent Penems

26 Mar 2024 Evaluate

Solara Active Pharma Sciences has received approval from board of directors to sell 100% shareholding in SeQuent Penems. The board of directors of the company at its meeting held on March 25, 2024 approved the same.  

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..